Previous Page  30 / 156 Next Page
Information
Show Menu
Previous Page 30 / 156 Next Page
Page Background

446

Jun;233(2):553-61.

13. Hagberg H, Ichord R, Palmer C, Yager JY, Vannucci SJ. Animal

models of developmental brain injury: relevance to human

disease. A summary of the panel discussion from the Third

Hershey Conference on Developmental Cerebral Blood Flow

and Metabolism. Acta Paediatr. 2002;91(12):1357-63.

14. Patterson PH. Maternal infection and autismo. Brain Behav

Immun. 2012 Mar;26(3):393.

15. Ilievski V, Lu SJ, Hirsch E. Activation of toll-like receptors 2

or 3 and preterm delivery in the Mouse. Reprod Sci. 2007

May;14(4):315-20.

16. Jun-Ming Zhang, Jianxiong An. Cytokines, Inflammation

and Pain. Int Anesthesiol Clin. 2007 Spring; 45(2): 27–37.

17. Renaud SJ, Graham CH. The role of macrophages in utero-

placental interactions during normal and pathological

pregnancy. Immunol Invest. 2008;37(5):535-64.

18. Hsiao EY, Patterson PH. Activation of the maternal immune

system induces endocrine changes in the placenta via IL-6.

Brain Behav Immun. 2011 May;25(4):604-15.

19. Anderson GM1, Jacobs-Stannard A, Chawarska K, Volkmar

FR, Kliman HJ. Placental trophoblast inclusions in autism

spectrum disorder. Biol Psychiatry. 2007 Feb 15;61(4):487-

91.

20. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson

RL Jr, Moore M, et al. Positive screening for autism in

ex-preterm infants: prevalence and risk factors. Pediatrics.

2008 Apr;121(4):758-65.

21. Brown AS, Susser ES. Prenatal nutritional deficiency

and risk of adult schizophrenia. Schizophr Bull. 2008

Nov;34(6):1054-63.

22. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE,

Lemcke S, Abdallah M, et al. Maternal infection requiring

hospitalization during pregnancy and autism spectrum

disorders. J Autism Dev Disord. 2010 Dec;40(12):1423-30.

23. Brown AS, Patterson PH. Maternal infection and

schizophrenia: implications for prevention. Schizophr Bull.

2011;37:284–290.

24. O’Callaghan ME, MacLennan AH, Gibson CS, McMichael GL,

Haan EA, Broadbent JL, et al. Epidemiologic associations

with cerebral palsy. Obstetrics and Ginecology. 2011;

118:576–582.

25. Redline RW. Placental pathology and cerebral palsy. Clin

Perinatol.2006; 33:503–516.

26. Bonnin A, Goeden N, Chen K, Wilson ML, King J, et al.

A transient placental source of serotonin for the fetal

forebrain. Nature. 2011. 472:347–350.

27. Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, et al. The

emergence of hematopoietic stem cells is initiated in the

placental vasculature in the absence of circulation. Cell

Stem Cell. 2008. 2:252–263.

28. Barbazanges A, Vallee M, Mayo W, Day J, Simon H, Le Moal

M, Maccari S. Early and later adoptions have different long-

term effects on male rat offspring . J Neurosci. 1996. 16:

7783–7790.

29. Schneider ML: Growth and development following prenatal

stress exposure in primates an examination of ontogenetic

vulnerability. Child Dev. 1999; 70: 263.

30. Romero R, Kadar N, Hobbins JC, Duff GW. Infection and

labor: the detection of endotoxin in amniotic fluid. Am J

Obstet Gynecol. 1987 Oct;157(4 Pt 1):815-9.

31. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM.

The fetal inflammatory response syndrome. Am J Obstet

Gynecol. 1998 Jul;179(1):194-202.

32. R. Gomez, F. Ghezzi, R. Romero, B.H. Yoon, M. Mazor, S.M.

Berry. Two thirds of human fetuses with microbial invasion

of the amniotic cavity have a detectable systemic cyto-kine

response before Barth. Am J Obstet Gynecol. 1997. 176:

514.

33. Iida K, Takashima S, Takeuchi Y. Etiologies and distribution

of neonatal leukomalacia. Pediatr Neurol. 1992

May-Jun;8(3):205-9.

34. Van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, et

al. Activation of coagulation after administration of tumor

necrosis factor to normal subjects. N Engl J Med. 1990 Jun

7;322(23):1622-7.

35. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis

factor/cachectin stimulates peritoneal macrophages,

polymorphonuclear neutrophils, and vascular endothelial

cells to synthesize and release platelet-activating factor. J

Exp Med. 1987 Nov 1;166(5):1390–1404.

36. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin

and oligodendrocyte damage in Vitro. Ann Neurol. 1988

Apr;23(4):339-46.

37. Doyle

LW.

Antenatal

magnesium

sulfate

and

neuroprotection. Curr Opin Pediatr. 2012 Apr;24(2):154-9.

38. Beloosesky R, Gayle DA, Amidi F, Nunez SE, Babu J, et al.

N-acetyl-cysteine suppresses amniotic fluid and placenta

inflammatory cytokine responses to lipopolysaccharide in

rats. Am J Obstet Gynecol. 2006 Jan;194(1):268-73.

39. Wang X, Svedin P, Nie C, Lapatto R, Zhu C, Gustavsson

M, et al. N-acetylcysteine reduces lipopolysaccharide-

sensitized hypoxic-ischemic brain injury. Ann Neurol. 2007

Mar;61(3):263-71.

[REV. MED. CLIN. CONDES - 2016; 27(4) 441-446]